Panel discussion: The first active immunotherapy for cancer

Panel discussion "The first active immunotherapy for cancer - what went right and wrong, lessons to be learned, and will it taint the field of immunotherapy" moderated by Charles C. Duncan, Ph.D., of JMP Securities LLC, from MD Becker Partners' 2nd Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference held October 6, 2011 in New York City. For more information about MD Becker Partners, visit: www.mdbpartners.com